Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company's strong revenue growth, increased order backlog, and positive EPS growth suggest a favorable market outlook. The anticipated operational status of Ironbeam and a robust defense budget outlook in key regions further support this sentiment. Despite some concerns about regulatory risks and financial expenses, the overall sentiment from the earnings call and Q&A session indicates a positive market reaction, likely resulting in a stock price increase of 2% to 8% over the next two weeks.
Revenue $1,896,000,000 (22% increase year-over-year from $1,554,000,000) due to robust demand across all key geographies.
GAAP Gross Margin 24% (decrease from 24.1% year-over-year) due to operational factors.
Non-GAAP Gross Margin 24.3% (decrease from 24.7% year-over-year) due to operational factors.
GAAP Operating Income $149,700,000 (increase from $105,400,000, 7.9% of revenues compared to 6.8% year-over-year) due to revenue growth.
Non-GAAP Operating Income $100,000,000 (increase from previous year, specific figures not provided) due to revenue growth.
Net R&D Expenses $114,300,000 (6.1% of revenues, decrease from 6.3% year-over-year) due to operational efficiencies.
Marketing and Selling Expenses $100,900,000 (5.3% of revenues, decrease from 5.7% year-over-year) due to operational efficiencies.
G&A Expenses $89,400,000 (4.7% of revenues, decrease from 5.2% year-over-year) due to operational efficiencies.
Financial Expenses $39,000,000 (increase from $31,200,000 year-over-year) due to hedging transactions and currency exchange rate changes.
Tax Expense $16,100,000 (increase from $11,600,000 year-over-year) with an effective tax rate of 13.9% compared to 14.6%.
GAAP Diluted EPS $2.35 (increase from $1.65 year-over-year) due to increased net income.
Non-GAAP Diluted EPS $2.57 (increase from $1.81 year-over-year) due to increased net income.
Free Cash Flow $161,000,000 (strong performance, specific year-over-year comparison not provided) due to increased net income and contract liabilities.
Net Cash Provided by Operating Activities $184,000,000 (compared to cash used of $6,000,000 in the previous year) due to increased net income and contract liabilities.
Order Backlog $23,100,000,000 (increase of $2.7 billion year-over-year) due to strong demand in defense spending.
IronBeam System: The IronBeam system, a high power laser solution, is expected to be operational by the end of 2025, with strong interest from various countries.
Advanced Rocket Munition Launcher PULSE: Elbit's PULSE system has been selected by multiple European countries, enhancing defense capabilities in modern battlefields.
Joint National Digital Fire Command Centers: A contract worth approximately $100 million was secured to provide these centers for European countries.
Advanced Airborne Self Protection Suits: Contracts totaling $80 million were awarded to supply advanced self-protection suits for the F-16I fleet.
Maritime Electronic Warfare Solution: A contract was won for a maritime EW self-protection solution for a NATO European country.
Redrawn Counter UAS Solution: A contract was secured for a multi-sensor and multi-mission system to detect and locate multiple drones.
Soldier Lethality Program: A $112 million contract was announced for the U.S. Marine Corps, focusing on infantry soldier enhancements.
Geographical Expansion: Elbit's growth is supported by strong demand in Israel, U.S., Europe, and Asia Pacific, with 66% of the backlog from outside Israel.
Defense Spending Increase: Ongoing conflicts are driving increased defense budgets globally, particularly in Europe, with NATO proposing to increase defense spending to 5% of GDP by 2032.
Free Cash Flow: Strong free cash flow of $161 million was reported, with a conversion rate of nearly 140% on adjusted net income.
Operating Cash Flow: Operating cash flow was positively impacted by increased net income and contract liabilities.
CapEx Investment: CapEx is expected to increase slightly to around $250 million from $215 million in 2024.
Focus on Defense Solutions: Elbit continues to focus on defense solutions, with a commitment to enhancing deterrence capabilities in Israel and Europe.
Operational Efficiency: The company aims to leverage operational efficiencies to improve profitability while managing high demand.
Geopolitical Risks: Ongoing conflicts in Ukraine and the Middle East may impact defense spending and investment decisions. However, the company believes that these conflicts will lead to increased defense budgets globally.
Market Demand Risks: There is a potential risk of a slowdown in defense activity in Israel if there is a decline in conflict intensity or a ceasefire, which could affect future orders and revenue.
Supply Chain Challenges: The company faces challenges related to supply chain management, particularly in the context of increased demand for defense products and the need to build inventories.
Regulatory Risks: Changes in government policies and regulations regarding defense spending, particularly in NATO countries, could impact the company's operations and revenue.
Financial Risks: Increased financial expenses due to hedging transactions and currency exchange rate fluctuations may affect profitability.
Operational Risks: The company is focused on operational leverage to maintain profitability, but reliance on this strategy may pose risks if demand does not continue to grow as expected.
Investment Risks: The company plans to increase CapEx to around $250 million, which may pose risks if the expected returns on these investments do not materialize.
Backlog Growth: The backlog has reached a record of $23.1 billion, up 40% from last year.
Defense Spending Trends: Ongoing conflicts are driving increased defense budgets globally, particularly in Europe and Israel.
New Contracts: Secured contracts include approximately $100 million for joint national digital fire command centers and $80 million for advanced airborne self-protection suits.
IronBeam Development: The IronBeam system is expected to be operational by the end of 2025, with significant interest in its capabilities.
Revenue Growth: Expecting continued double-digit revenue growth driven by strong demand across all segments.
CapEx Expectations: CapEx is expected to increase slightly to around $250 million from $215 million in 2024.
Gross Profit Margin: Improvement in gross profit margin is anticipated through operational leverage and selective bookings.
Free Cash Flow: Strong free cash flow generation is expected to continue, driven by increased net income and contract liabilities.
Dividend per share: $0.60 per share declared by the Board of Directors.
Free cash flow: $161,000,000 generated in the first quarter.
The earnings call highlights strong financial performance with significant revenue growth and margin expansion, despite some segment declines. The company's strategic plans, including a $1.625 billion European contract and new orders, indicate robust future growth potential. The Q&A reveals optimism in international expansion and emerging technologies, boosting sentiment. While guidance was not specific, internal targets remain positive. Overall, the combination of strong past performance and strategic growth initiatives suggests a positive outlook for the stock price over the next two weeks.
The earnings call reveals strong financial performance, with significant revenue growth across segments, improved margins, and increased cash flow. The Q&A section highlighted strategic developments like the IronBeam and UAS systems, and margin expansion efforts. Despite management's reluctance to provide formal guidance, the robust backlog and growth projections, alongside a successful turnaround of ESA, suggest a positive outlook. The overall sentiment is positive, driven by strong earnings, optimistic growth targets, and strategic advancements, likely leading to a stock price increase in the short term.
Elbit Systems reported strong revenue and EPS growth, robust demand, and a significant backlog increase. The share buyback program further supports a positive outlook. While gross margins slightly decreased, the company's strategic initiatives, including AI integration and new product development, are promising. The Q&A highlighted management's confidence in future demand and operational improvements. Despite competitive pressures and regulatory challenges, the overall sentiment is positive, likely leading to a stock price increase of 2% to 8% over the next two weeks.
Elbit's earnings call highlights strong financial performance with significant revenue growth and improved EPS. The backlog increase and positive defense budget outlook in key regions further support a positive sentiment. Despite slight margin compression, the company's strategic investments in AI and production capacity, along with a declared dividend, enhance shareholder confidence. The Q&A session did not reveal any major concerns, and management's optimism about future demand and growth opportunities reinforces a positive outlook for the stock price over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.